Nina Capital

www.nina.capital

NINA Capital invests in healthcare transformation powered by information technology and led by need-driven founders. They focus on pre-seed to seed+ stages with ticket sizes from €200k to €1.5M across pan-European, US, Canadian, Israeli, and Australian markets.

Check Size

$200K - $1.5M

Stages

Pre Seed, Seed, Series A

Focus Areas

Healthtech, Digital Health, Ai Ml

Is Nina Capital right for your startup?

Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.

See If You're a Match

Investment Thesis

NINA Capital invests exclusively at the intersection of healthcare and technology, guided by the Stanford Biodesign methodology of health technology innovation. They believe in a need-driven, value-based approach to healthcare transformation, confident that ‘need-driven technology ventures generate the highest value in healthcare and for their investors.’ Their philosophy centers on backing thoughtful, committed founders who combine deep understanding of healthcare system complexity with meaningful engineering innovation and advanced data science.

What Sets Them Apart

Specialized focus exclusively on healthcare-technology intersection with Biodesign methodology foundation
Need-driven founder requirement - founders must have deep understanding of healthcare unmet needs
Pan-European headquarters with international ambitions requirement for portfolio companies
Explicit exclusion of drugs and vaccines, focusing on healthcare tools and digital solutions
Strong emphasis on team diversity and multidisciplinary composition as investment criterion
Collaborative approach to syndication - founders choose their partners rather than NINA controlling the syndicate
Founded by Stanford faculty member with deep healthcare innovation expertise
Integration of sustainability and ESG criteria throughout investment process